Sign in to continue:

Sunday, February 1st, 2026

Clearbridge Health Limited Issues Corrigendum for Q3 2024 Financial Results








Clearbridge Health Limited Financial Analysis – Q3FY24

Clearbridge Health Limited Financial Analysis – Q3FY24

Business Description

Clearbridge Health Limited is incorporated in the Republic of Singapore. The company, along with its subsidiaries, operates in the healthcare sector focusing on providing healthcare solutions and services. The geographic footprint of the company and its specific business segments are not detailed in the report provided.

Industry Position and Market Share

The report does not provide specific information about Clearbridge Health Limited’s position within the industry, its competitors, or its market share. This information is critical for understanding the company’s competitive landscape and should be further investigated by potential investors.

Revenue Streams and Competitive Advantage

The report does not elaborate on the company’s revenue streams, customer base, supply chain, or competitive advantages. Investors would need to look into these aspects separately to gain a comprehensive understanding of the company’s business operations.

Financial Statement Analysis

The document provided is a corrigendum to the Q3FY24 Results Announcement and does not include the primary financial statements such as the Income Statement, Balance Sheet, or Cash Flow Statement. Therefore, an analysis of these statements is not possible from the information given.

Key Information

  • The report highlights that the striking off of the dormant subsidiary, Golden Bridge Pte. Ltd., does not have a material impact on the company’s financial position for the third quarter and nine months ended 30 September 2024, nor is it expected to impact the full year ending 31 December 2024 [[1], [2]].
  • No dividend information, earnings increase or decrease, or special activities to improve profitability are detailed in the report.

Report Date and Financial Year

The corrigendum was released on 20 November 2024, concerning the financial results for the third quarter and nine months ended 30 September 2024 [[3]].

Investment Recommendations

For Current Shareholders

If you are currently holding this stock, it is recommended to maintain your position given the lack of negative impact from recent corporate activities. However, further analysis of the complete financial statements and business operations is advised for a more informed decision.

For Potential Investors

If you are not currently holding this stock, it is recommended to wait for more comprehensive data on the company’s financial health and market position before making an investment decision. Analyzing complete financial statements and understanding the company’s competitive landscape is crucial.

Disclaimer

This recommendation is based solely on the information provided in the corrigendum document. Investors should conduct their own research and consider their financial situation before making investment decisions.




View Clearbridge Historical chart here



Tosei Corporation Revises Earnings and Dividend Forecasts for Fiscal Year Ending November 30, 2024

Key Facts in the Report: Date of the Report: October 7, 2024. Financial Year Covered: December 1, 2023, to November 30, 2024. Notable Points for Investor Actions: Earnings Revision: Consolidated Revenue: Revised to ¥81,921...

Telstra Corporation Limited FY2024 Full Year Results: Strategic Growth through Infrastructure Investment Amid Earnings Decline

Key Facts from the Full Year Financial Results (Telstra Corporation Limited) for the Financial Year Ended 30 June 2024: Date of Report: 20 September 2024 Financial Year: 1 July 2023 – 30 June 2024...

PT Wilton Makmur Indonesia Tbk 2025 Interim Financial Report: Nine-Month Results, Ownership, and No Dividend Distribution

PT Wilton Makmur Indonesia Tbk (WMII): Interim September 2025 Financial Analysis PT Wilton Makmur Indonesia Tbk (“WMII” or “the Group”) is a listed gold mining company operating predominantly in Indonesia. This analysis reviews the...